{"pmid":32464272,"title":"Uganda's First 100 COVID-19 Cases: Trends and Lessons.","text":["Uganda's First 100 COVID-19 Cases: Trends and Lessons.","Int J Infect Dis","Olum, Ronald","Bongomin, Felix","32464272"],"journal":"Int J Infect Dis","authors":["Olum, Ronald","Bongomin, Felix"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464272","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ijid.2020.05.073","locations":["Uganda"],"countries":["Uganda"],"countries_codes":["UGA|Uganda"],"topics":["Prevention"],"weight":1,"_version_":1668079521263255552,"score":9.490897,"similar":[{"pmid":32437000,"title":"HIV and SARS-CoV-2 co-infection: A case report from Uganda.","text":["HIV and SARS-CoV-2 co-infection: A case report from Uganda.","There are no reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV co-infection from sub-Saharan Africa where 70% of people living with HIV are found. We report a case of HIV/SARS-CoV-2 co-infection from Uganda. A 34 year old HIV-positive female on antiretroviral therapy (tenofovir disoproxil fumarate, lamivudine and efavirenz) for 5 years, tested positive for SARS-CoV-2, the causative agent for coronavirus disease 19 (COVID-19). She was asymptomatic at presentation but subsequently developed headache, chest pain, diarrhoea, anorexia and fatigue on day 3 of isolation without cough, fever or shortness of breath. Her CD4 count was 965 cells/mm(3) , the HIV viral load was undetectable (<1,000 cells/mm(3) ) and other laboratory work up was normal. She was successfully managed with hydroxychloroquine and broad spectrum antibiotics, and was discharged after 24 days. This case demonstrates an atypical clinical presentation of COVID - 19 in an HIV infected patient without other co-morbidity. This article is protected by copyright. All rights reserved.","J Med Virol","Baluku, Joseph Baruch","Mwebaza, Shem","Ingabire, Gloria","Nsereko, Chris","Muwanga, Moses","32437000"],"abstract":["There are no reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV co-infection from sub-Saharan Africa where 70% of people living with HIV are found. We report a case of HIV/SARS-CoV-2 co-infection from Uganda. A 34 year old HIV-positive female on antiretroviral therapy (tenofovir disoproxil fumarate, lamivudine and efavirenz) for 5 years, tested positive for SARS-CoV-2, the causative agent for coronavirus disease 19 (COVID-19). She was asymptomatic at presentation but subsequently developed headache, chest pain, diarrhoea, anorexia and fatigue on day 3 of isolation without cough, fever or shortness of breath. Her CD4 count was 965 cells/mm(3) , the HIV viral load was undetectable (<1,000 cells/mm(3) ) and other laboratory work up was normal. She was successfully managed with hydroxychloroquine and broad spectrum antibiotics, and was discharged after 24 days. This case demonstrates an atypical clinical presentation of COVID - 19 in an HIV infected patient without other co-morbidity. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Baluku, Joseph Baruch","Mwebaza, Shem","Ingabire, Gloria","Nsereko, Chris","Muwanga, Moses"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437000","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26044","keywords":["covid-19","hiv","sars-cov-2","uganda"],"locations":["Uganda","Uganda"],"countries":["Uganda"],"countries_codes":["UGA|Uganda"],"e_drugs":["Tenofovir","Hydroxychloroquine","efavirenz","Lamivudine"],"topics":["Case Report"],"weight":1,"_version_":1667521393570349056,"score":47.098293},{"pmid":32144096,"title":"Covid-19: UK records first death, as world's cases exceed 100 000.","text":["Covid-19: UK records first death, as world's cases exceed 100 000.","BMJ","Mahase, Elisabeth","32144096"],"journal":"BMJ","authors":["Mahase, Elisabeth"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32144096","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1136/bmj.m943","locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["General Info"],"weight":1,"_version_":1666138492752625666,"score":44.16748},{"pmid":32434776,"title":"Legal preparedness as part of COVID-19 response: the first 100 days in Taiwan.","text":["Legal preparedness as part of COVID-19 response: the first 100 days in Taiwan.","BMJ Glob Health","Lee, Tsung-Ling","32434776"],"journal":"BMJ Glob Health","authors":["Lee, Tsung-Ling"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434776","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/bmjgh-2020-002608","keywords":["health policies and all other topics","health systems","infections, diseases, disorders, injuries","prevention strategies","public health"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667521393631166464,"score":42.875023}]}